Stay updated on Ponatinib for Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ponatinib for Medullary Thyroid Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and revision v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-24T17:48:03.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The funding-status notice about lapse in government funding has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T17:27:29.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The study status is Withdrawn/Closed by sponsor with enrollment at 0, indicating no active recruitment.
    Difference
    0.5%
    Check dated 2025-11-03T12:11:38.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    - Updated page to v3.2.0 and removed the Medullary thyroid carcinoma resource. - Added a government funding/operating-status notice directing users to NIH and OPM sites for current operations.
    Difference
    5%
    Check dated 2025-10-05T16:44:31.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Core content terminology updated from “Medullary thyroid gland carcinoma” to “Medullary thyroid carcinoma” and the release version updated to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T09:55:45.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2 and the 'Back to Top' link was removed; no core content or pricing/availability changes detected.
    Difference
    0.2%
    Check dated 2025-09-14T00:16:03.000Z thumbnail image

Stay in the know with updates to Ponatinib for Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.